CHAPEL, H., M. LUCAS, M. LEE, J. BJORKANDER, D. WEBSTER, B. GRIMBACHER, C. FIESCHI, Vojtěch THON, MR. ABEDI and L. HAMMARSTROM. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008, 2008/112, No 2, p. 277-286. ISSN 0006-4971.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Common variable immunodeficiency disorders: division into distinct clinical phenotypes
Name in Czech Běžná variabilní imunodeficience: rozdělení odlišných fenotypů
Authors CHAPEL, H., M. LUCAS, M. LEE, J. BJORKANDER, D. WEBSTER, B. GRIMBACHER, C. FIESCHI, Vojtěch THON, MR. ABEDI and L. HAMMARSTROM.
Edition Blood, 2008, 0006-4971.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 10.432
Organization unit Faculty of Medicine
UT WoS 000257696300016
Keywords (in Czech) imunodeficience; běžná variabilní imunodeficience
Keywords in English DISEASES CLASSIFICATION COMMITTEE; ANTIBODY DEFICIENCY; IMMUNE DEFICIENCY; B CELL; PRIMARY HYPOGAMMAGLOBULINEMIA; IMMUNOLOGICAL FEATURES; INTERNATIONAL UNION; T CELL; MANIFESTATIONS; COMPLICATIONS
Tags ANTIBODY DEFICIENCY, B CELL, complications, DISEASES CLASSIFICATION COMMITTEE, immune deficiency, IMMUNOLOGICAL FEATURES, INTERNATIONAL UNION, MANIFESTATIONS, PRIMARY HYPOGAMMAGLOBULINEMIA, T cell
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Vojtěch Thon, Ph.D., učo 2483. Changed: 18/6/2009 12:11.
Abstract
The European Common Variable Immunodeficiency Disorders registry was started in 1996 to define distinct clinical phenotypes and determine overlap within individual patients. A total of 7 centers contributed patient data, resulting in the largest cohort yet reported. Patients (334), validated for the diagnosis, were followed for an average of 25.6 years (9461 patientyears). Data were used to define 5 distinct clinical phenotypes: no complications, autoimmunity, polyclonal lymphocytic infiltration, enteropathy, and lymphoid ma-lignancy. A total of 83% of patients had only one of these phenotypes. Analysis of mortality showed a considerable reduction in the last 15 years and that different phenotypes were associated with different survival times. Types of complications and clinical phenotypes varied significantly between countries, indicating the need for large, international registries. Ages at onset of symptoms and diagnosis were shown to have a Gaussian distribution, but were not useful predictors of phenotype. The only clinical predictor was polyclonal lymphocytic infiltration, which was associated with a 5-fold increased risk of lymphoid malignancy. There was widespread variation in the levels of serum immunoglobulin isotypes as well as in the percentages and absolute numbers of B cells, confirming the heterogeneity of these conditions. Higher serum IgM and lower circulating CD8 proportions were found to be predictive markers for polyclonal lymphocytic infiltration and autoimmunity, respectively.
Abstract (in Czech)
Běžná variabilní imunodeficience: rozdělení odlišných fenotypů
Links
NR9035, research and development projectName: Specifická protilátková odpověď u pacientů s poruchami imunity
PrintDisplayed: 21/7/2024 10:22